{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:03:32Z","timestamp":1791241412444,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chang Gang Medical Foundation-Kaohsiung Branch","award":["CMRPG8H0451"],"award-info":[{"award-number":["CMRPG8H0451"]}]},{"name":"Chang Gang Medical Foundation-Kaohsiung Branch","award":["CMRPG8H0452"],"award-info":[{"award-number":["CMRPG8H0452"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Extracorporeal shock wave therapy (ESWT) has been shown to improve symptoms in patients with interstitial cystitis\/bladder pain syndrome (IC\/BPS); however, there is a lack of objective evidence. We measured change of urinary biomarker levels in 25 patients with IC\/BPS received ESWT or placebo once a week for 4\u00a0weeks. Urines were collected from participants at baseline, 4 and 12\u00a0weeks post treatment. A representative 41 inflammatory growth factors, cytokines, and chemokines in urine were measured using a MILLIPLEX immunoassay kit. Symptom bother was assessed by O\u2019Leary-Sant symptom scores (OSS), and visual analog scale (VAS) for pain. The ESWT group exhibited a significant reduction in the OSS and VAS compared to the placebo group 4\u00a0weeks post-treatment (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05), and the effects were persistent at 12\u00a0weeks. The difference in urinary markers change in ESWT versus placebo was\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.054 for IL4,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.013 for VEGF, and\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.039 for IL9 at 4\u00a0weeks. The change of urine biomarker was not significant in other biomarkers or all the measured proteins at 12\u00a0weeks. The current data suggest that IL4, IL9, and VEGF mediation may be involved in its pathophysiologic mechanisms and response to LESW treatment.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-87040-1","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T06:02:48Z","timestamp":1617688968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Improves symptoms and urinary biomarkers in refractory interstitial cystitis\/bladder pain syndrome patients randomized to extracorporeal shock wave therapy versus placebo"],"prefix":"10.1038","volume":"11","author":[{"given":"Yuan-Chi","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chancellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chi","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"87040_CR1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno, P. M. et al. Diagnosis and treatment of\u00a0interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J. Urol. 193, 1545\u20131553 (2015).","journal-title":"J. Urol."},{"key":"87040_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/luts.12214","volume":"10","author":"E Meng","year":"2018","unstructured":"Meng, E., Hsu, Y. C. & Chuang, Y. C. Advances in intravesical therapy for bladder pain syndrome (BPS)\/interstitial cystitis (IC). Lower Urin. Tract Symptoms 10, 3\u201311 (2018).","journal-title":"Lower Urin. Tract Symptoms"},{"key":"87040_CR3","doi-asserted-by":"publisher","first-page":"15218","DOI":"10.1038\/s41598-020-72292-0","volume":"10","author":"YH Jiang","year":"2020","unstructured":"Jiang, Y. H. et al. Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis. Sci. Rep. 10, 15218 (2020).","journal-title":"Sci. Rep."},{"issue":"484","key":"87040_CR4","first-page":"e7","volume":"79","author":"JH Shie","year":"2012","unstructured":"Shie, J. H., Liu, H. T. & Kuo, H. C. Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis\/painful bladder syndrome. Urology 79(484), e7-13 (2012).","journal-title":"Urology"},{"key":"87040_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41443-019-0113-3","volume":"31","author":"T Liu","year":"2019","unstructured":"Liu, T., Shindel, A. W., Lin, G. & Lue, T. F. Cellular signaling pathways modulated by low-intensity extracorporeal shock wave therapy. Int. J. Impot. Res. 31, 170\u2013176 (2019).","journal-title":"Int. J. Impot. Res."},{"key":"87040_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5213\/inj.2040104.052","volume":"24","author":"CC Lin","year":"2020","unstructured":"Lin, C. C., Huang, Y. C., Lee, Y. C. & Chuang, Y. C. New frontiers for the treatment of interstitial cystitis\/bladder pain syndrome\u2014focused on stem cells, platelet-rich plasma, and low-energy shock wave. Int. Neurourol. J. 24, 211\u2013221 (2020).","journal-title":"Int. Neurourol. J."},{"issue":"6","key":"87040_CR7","first-page":"9175676","volume":"2020","author":"YCSMKLWC LeeChuangLinChen","year":"2020","unstructured":"LeeChuangLinChen, Y. C. S. M. K. L. W. C. et al. Low-intensity extracorporeal shock wave therapy ameliorates the overactive bladder: a prospective pilot study. Biomed. Res. Int. 2020(6), 9175676 (2020).","journal-title":"Biomed. Res. Int."},{"key":"87040_CR8","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/nau.24382","volume":"39","author":"YC Chuang","year":"2020","unstructured":"Chuang, Y. C., Meng, E., Chancellor, M. & Kuo, H. C. Pain reduction realized with extracorporeal shock wave therapy for the treatment of symptoms associated with interstitial cystitis\/bladder pain syndrome\u2014a prospective, multicenter, randomized, double-blind, placebo-controlled study. Neurourol. Urodyn. 39, 1505\u20131514 (2020).","journal-title":"Neurourol. Urodyn."},{"key":"87040_CR9","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/nau.23141","volume":"36","author":"HJ Wang","year":"2017","unstructured":"Wang, H. J., Lee, W. C., Tyagi, P., Huang, C. C. & Chuang, Y. C. Effects of low energy shock wave therapy on inflammatory moleculars, bladder pain, and bladder function in a rat cystitis model. Neurourol. Urodyn. 36, 1440\u20131447 (2017).","journal-title":"Neurourol. Urodyn."},{"key":"87040_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11255-009-9647-5","volume":"42","author":"P Tyagi","year":"2010","unstructured":"Tyagi, P. et al. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int. Urol. Nephrol. 42, 629\u2013635 (2010).","journal-title":"Int. Urol. Nephrol."},{"issue":"971","key":"87040_CR11","first-page":"e11","volume":"78","author":"JD Lee","year":"2011","unstructured":"Lee, J. D. & Lee, M. H. Increased expression of hypoxia-inducible factor-1\u03b1 and ascular endothelial growth factor associated with glomerulation formation in patients with interstitial cystitis. Urology 78(971), e11-15 (2011).","journal-title":"Urology"},{"key":"87040_CR12","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1464-410X.2009.08467.x","volume":"104","author":"H Kiuchi","year":"2009","unstructured":"Kiuchi, H. et al. Increased vascular endothelial growth factor expression in patients with bladder pain syndrome\/interstitial cystitis:its association with pain severity and glomerulations. BJU Int. 104, 826\u2013831 (2009).","journal-title":"BJU Int."},{"issue":"1452","key":"87040_CR13","first-page":"e1","volume":"82","author":"CH Peng","year":"2013","unstructured":"Peng, C. H., Jhang, J. F., Shie, J. H. & Kuo, H. C. Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis\u2014clinical results and immunohistochemistry analysis. Urology 82(1452), e1-6 (2013).","journal-title":"Urology"},{"key":"87040_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/bju.13924","volume":"120","author":"HH Lai","year":"2017","unstructured":"Lai, H. H. et al. Anti-vascular endothelial growth factor treatment decreases bladder pain in cyclophosphamide cystitis: a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network animal model study. BJU Int. 120, 576\u2013583 (2017).","journal-title":"BJU Int."},{"key":"87040_CR15","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1016\/S0022-5347(05)64241-3","volume":"168","author":"K Sugaya","year":"2002","unstructured":"Sugaya, K. et al. Molecular analysis of adrenergic receptor genes and interleukin-4\/interleukin-4 receptor genes in patients with interstitial cystitis. J. Urol. 168, 2668\u20132671 (2002).","journal-title":"J. Urol."},{"key":"87040_CR16","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0022-5347(05)00167-9","volume":"175","author":"K Bouchelouche","year":"2006","unstructured":"Bouchelouche, K. et al. Interleukin-4 and 13 induce the expression and release of monocyte chemoattractant protein 1, interleukin-6 and stem cell factor from human detrusor smooth muscle cells: synergy with interleukin-1beta and tumor necrosis factor-alpha. J. Urol. 175, 760\u2013765 (2006).","journal-title":"J. Urol."},{"issue":"4","key":"87040_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.it.2011.01.006","volume":"32","author":"NB Perumal","year":"2011","unstructured":"Perumal, N. B. & Kaplan, M. H. Regulating IL9 transcription in T helper cells. Trends Immunol. 32(4), 146\u2013150 (2011).","journal-title":"Trends Immunol."},{"key":"87040_CR18","doi-asserted-by":"crossref","unstructured":"Chancellor, M. B. & Lamb, L. E. Toward a validated diagnostic test with machine learning algorithm for interstitial cystitis. Urol. Sci. 32, 2\u20137 (2021).","DOI":"10.4103\/UROS.UROS_155_20"},{"key":"87040_CR19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0022-5347(05)67873-1","volume":"163","author":"R Peeker","year":"2000","unstructured":"Peeker, R., Enerback, L., Fall, M. & Aldenborg, F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J. Urol. 163, 1009\u20131015 (2000).","journal-title":"J. Urol."},{"issue":"11","key":"87040_CR20","doi-asserted-by":"publisher","first-page":"e0143316","DOI":"10.1371\/journal.pone.0143316","volume":"10","author":"D Maeda","year":"2015","unstructured":"Maeda, D. et al. Hunner-type (classic) interstitial cystitis: a distinct inflammatory disorder characterized by pancystitis, with frequent expansion of clonal B-cells and epithelial denudation. PLoS ONE 10(11), e0143316 (2015).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87040-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T01:24:44Z","timestamp":1670030684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87040-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["87040"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-87040-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-111102\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"18 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7558"}}